Introduction: Why Pathology Workflows Are Now a Critical NHS Pressure Point
Pathology result management in primary care has become one of the most time-consuming, risk-laden, and clinically frustrating workflows in general practice. Every day, thousands of “normal” results arrive in EMIS or SystmOne—each requiring clinician review, contextual interpretation, medication checks, and safe filing. In theory, this sounds simple. In reality, it has become unsustainable.
Normal pathology filing should be fast and safe. Instead, it consumes hours of clinical time, drives decision fatigue, and leaves practices exposed to inconsistent triage, human error, and variation in judgment. The process was designed for a world without 200,000+ tests a day, rising multimorbidity, and shrinking workforce capacity. It has not kept pace with modern expectations of safety, scale, or standardisation.
This is the context in which MyBotGP Pathology, a DCB0129-certified Medical Device, exists. It automates the safe filing of normal results—including contextual safety checks, medication reviews, and intelligent pattern-change analysis—while flagging anything requiring clinician input. Practices using MyBotGP typically save 95 days of clinical time per year, recovering roughly £50,000 in GP cost and dramatically reducing unnecessary workload and risk.
The Current Reality: A Process That Is Only Safe When GPs Have Unlimited Time
A typical GP sees 60–180 pathology results per day, depending on list size and testing culture. Each result requires:
- Reading the report
- Checking laboratory ranges
- Reviewing medications
- Analysing trends and percentage changes
- Checking clinical context and conditions
- Deciding whether it is truly “normal”
- Filing, assigning actions, or sending patient messages
Every step is clinically essential—and entirely manual.
Where the Risks Emerge in Manual Pathology Management
Even the most experienced clinicians face:
- ➢ Variation between GPs (normal vs abnormal interpretation differs)
- ➢ Variation between labs (ranges vary; PSA, renal, thyroid, and liver markers require context)
- ➢ Decision fatigue after hours of checking results
- ➢ Time pressure, especially for duty doctors
- ➢ Incomplete contextual review, a consequence of unrealistic workload
This exists alongside rising testing volume: chronic disease reviews, pre-op pathways, population health screening, medication monitoring, and safety-netting expectations.
In short: the current NHS pathology workflow relies on human perfection in a system designed to overwhelm humans.
Real-World Consequences: The Same Logic as AF Misdiagnosis, Applied to Pathology
You referenced the AF example: pulse-checking with a finger and a watch misses 25% of real AF (false negatives) and incorrectly refers 15% (false positives).
Pathology filing has the same vulnerability.
1. False negatives in pathology: concerning patterns missed entirely
False negatives occur when:
- ➢ A “normal” lab value is filed without checking medications
- ➢ Percentage increases or decreases are overlooked
- ➢ Age-adjusted markers (e.g., PSA) aren’t applied
- ➢ Lab ranges hide clinically relevant deterioration
- ➢ Co-morbidities and conditions aren’t reviewed
Consequences:
- ➢ Delayed diagnosis
- ➢ Disease progression
- ➢ Re-presentations to urgent care
- ➢ Complaints and medico-legal exposure
Even small percentage changes (10–30%) in renal, liver, thyroid or inflammatory markers can signify early deterioration—and are often missed during volume processing.
2.False positives: unnecessary workload and patient anxiety
Over-calling results occurs when:
- ➢ A GP is unsure due to range variation
- ➢ Personal risk tolerance varies
- ➢ Defensive medicine increases under time pressure
Consequences:
- ➢ Extra blood tests
- ➢ Repeat appointments
- ➢ Increased phone demand
- ➢ Higher admin load
- ➢ Patient worry and confusion
Just like AF detection, manual pathology management introduces both false negatives and false positives—each generating clinical, operational, and patient harm.
Why the Current Manual Process Is No Longer Fit for Purpose
The NHS encourages structured, consistent safety systems for results handling. However, manual methods are failing due to:
1. Inconsistent Contextual Review
Medication changes, conditions, admissions, % changes—review depth varies between clinicians, times of day, and workloads.
2. Lab Ranges ≠ Clinical Ranges
Many markers require clinically defined rules, not default lab thresholds.
3. Cognitive Overload
Manual filing often happens at the end of clinic or during on-call periods—when decision accuracy is lowest.
4. Massive Volume Growth
Demand continues to increase 20–40% due to population health strategies, chronic disease, and safety-netting.
5. NoStandardisation
Every GP, ANP, RMO, locum, or registrar has their own interpretation.
Variation = risk.
How MyBotGP Pathology Fixes the Structural Problems
MyBotGP is a DCB0129-certified, clinically safe automation system for EMIS and SystmOne.
1. Automated Filing of Normal Results
It reads, validates, checks context, applies rules, and files directly—sending SMS updates if required.
2. Consistent Automated Safety Checks
MyBotGP checks:
- ➢ Medications
- ➢ Chronic conditions
- ➢ Previous results
- ➢ % changes / trends
- ➢ Marker-specific rules
- ➢ Lab comments
If safe → files.
If not → flags.
No variation. No missed detail. No fatigue.
3. Supersedes Lab Ranges Where Needed
PSA, renal markers, and certain subtests require more than lab ranges.
MyBotGP uses GP-defined or clinically validated rules.
4. StandardisedSafety Across the Practice
Every clinician’s decision-making becomes aligned.
5. Huge Time and Cost Savings
- ➢ 95 clinical days returned per year
- ➢ ~£50,000 cost saving
- ➢ Reduced risk, complaints, and workload
This is not a marginal improvement—it is a structural shift.
Why This Matters Now: The Risk Curve Is Steepening
The NHS workforce shortage, rising testing volume, complex multimorbidity, and higher medico-legal scrutiny mean the old method is no longer viable.
Just as AF detection evolved beyond a finger and a watch, pathology must evolve beyond manual triage. Errors are not a matter of skill—they are a matter of human limits.
What the Future Looks Like in 2–3 Years
Clinicians already using automated pathology filing say they could never return to manual workflows. Automation removes the noise; clinicians focus on the cases that matter.
Within two years, practices will not believe they ever:
- ➢ Checked normal results manually
- ➢ Cross-referenced medications for every test
- ➢ Scanned for % changes by eye
- ➢ Trusted lab ranges without context
- ➢ Batch-processed 100+ normals at speed
- ➢ Typed SMS messages manually
This shift mirrors ECG screening, cervical cytology, retinal photography—automation handles volume; clinicians handle judgement.
Conclusion: Safety, Time, and Standardisation
The current pathology workflow is unsafe, inconsistent, and impossible to scale.
Errors—false negatives, false positives, missed deterioration—are inherent to manual systems under pressure.
MyBotGP Pathology solves this with:
- ➢ Automated normal result filing
- ➢ Standardised safety checks
- ➢ Context-aware analysis
- ➢ Superseded lab ranges
- ➢ Trend and % change detection
- ➢ DCB0129-certified clinical safety
- ➢ £50,000 savings and 95 days returned annually
This isn’t about replacing clinical expertise.
It’s about protecting it, scaling it, and ensuring no patient slips through the cracks.
Automated pathology filing will become standard.
MyBotGP simply brings the future forward.